Page 100 - Read Online
P. 100

10.  Gassmann M, Shaban H, Vigot R, Sansig G, Haller C, Barbieri S,
                                                                  Humeau Y, Schuler V, Muller M, Kinzel B, Klebs K, Schmutz M,
                                                                  Froestl W, Heid J, Kelly PH, Gentry C, Jaton AL, Van der Putten H,
                                                                  Mombereau C, Lecourtier L, Mosbacher J, Cryan JF, Fritschy JM, Luthi
                                                                  A, Kaupmann K, Bettler B. Redistribution of GABAB (1) protein and
                                                                  atypical GABAB responses in GABAB(2)‑deficient mice. J Neurosci
                                                                  2004;24:6086‑97.
                                                              11.  Benarroch EE. GABAB receptors: structure, functions, and clinical
                                                                  implications. Neurology 2012;78:578‑84.
                                                              12.  Bowery NG, Bettler B, Froestl W, Gallagher JP, Marshall F, Raiteri M,
                                                                  Bonner TI, Enna SJ. International Union of Pharmacology. XXXIII.
                                                                  Mammalian  gamma‑aminobutyric  acid(B)  receptors:  structure  and
                                                                  function. Pharmacol Rev 2002;54:247‑64.
                                                              13.  Gambardella  A,  Manna  I,  Labate  A,  Chifari  R,  La  Russa  A,  Serra
                                                                  P, Cittadella R, Bonavita S,  Andreoli V, LePiane E, Sasanelli F, Di
                                                                  Costanzo A, Zappia M, Tedeschi G, Aguglia U, Quattrone A. GABA(B)
                                                                  receptor 1 polymorphism (G1465A) is associated with temporal lobe
                                                                  epilepsy. Neurology 2003;60:560‑3.
                                                              14.  Wang X, Sun W, Zhu X, Li L, Wu X, Lin H, Zhu S, Liu A, Du T, Liu Y, Niu
                                                                  N, Wang Y, Liu Y. Association between the gamma‑aminobutyric acid
           Figure 1: Suggested algorithm for approach to suspected autoimmune   type B receptor 1 and 2 gene polymorphisms and mesial temporal lobe
           encephalitis. [61‑63]  PERM: progressive encephalomyelitis with rigidity and   epilepsy in a Han Chinese population. Epilepsy Res 2008;81:198‑203.
           myoclonus; SMS: stiff‑man syndrome; MRI: magnetic resonance imaging; CSF:   15.  Enna SJ, Bowery NG. GABA (B) receptor alterations as indicators
           cerebrospinal fluid                                    of physiological and pharmacological function. Biochem Pharmacol
                                                                  2004;68:1541‑8.
           Financial support and sponsorship                  16.  Mombereau C, Kaupmann K, Froestl W, Sansig G, van der Putten H,
           Nil.                                                   Cryan JF. Genetic and pharmacological evidence of a role for GABA(B)
                                                                  receptors in the modulation of anxiety‑ and antidepressant‑like
                                                                  behavior. Neuropsychopharmacology 2004;29:1050‑62.
           Conflicts of interest                              17.  Hoftberger R, Titulaer MJ, Sabater L, Dome B, Rozsas A, Hegedus
           There are no conflicts of interest.                    B, Hoda MA, Laszlo V, Ankersmit HJ, Harms L, Boyero S, de Felipe
                                                                  A,  Saiz  A,  Dalmau  J,  Graus  F.  Encephalitis  and  GABAB  receptor
           REFERENCES                                             antibodies: novel findings in a new case series of 20 patients. Neurology
                                                                  2013;81:1500‑6.
           1.   Dalmau J, Tuzun E, Wu HY, Masjuan J, Rossi JE, Voloschin A, Baehring   18.  Kruer MC, Hoeftberger R, Lim KY, Coryell JC, Svoboda MD, Woltjer RL,
              JM, Shimazaki H,  Koide R, King D, Mason W, Sansing LH, Dichter MA,   Dalmau J.  Aggressive course in encephalitis with opsoclonus, ataxia,
              Rosenfeld MR, Lynch DR. Paraneoplastic anti‑N‑methyl‑D‑aspartate    chorea, and seizures: the first pediatric case of gamma‑aminobutyric
              receptor encephalitis associated with ovarian teratoma. Ann Neurol   acid type B receptor autoimmunity. JAMA Neurol 2014;71:620‑3.
              2007;61:25‑36.                                  19.  Mundiyanapurath S, Jarius S, Probst C, Stocker W, Wildemann B,
           2.   Lai M, Hughes EG, Peng X, Zhou L, Gleichman AJ, Shu H, Mata S,   Bosel J. GABA‑B‑receptor antibodies in paraneoplastic brainstem
              Kremens D, Vitaliani R, Geschwind MD, Bataller L, Kalb RG, Davis   encephalitis. J Neuroimmunol 2013;259:88‑91.
              R, Graus F, Lynch DR, Balice‑Gordon R, Dalmau J. AMPA receptor   20.  Jeffery OJ, Lennon VA, Pittock SJ, Gregory JK, Britton JW, McKeon
              antibodies in limbic encephalitis alter synaptic receptor location. Ann   A.  GABAB  receptor  autoantibody  frequency  in  service  serologic
              Neurol 2009;65:424‑34.                              evaluation. Neurology 2013;81:882‑7.
           3.   Lai M, Huijbers MG, Lancaster E, Graus F, Bataller L, Balice‑Gordon   21.  Kim TJ, Lee ST, Shin JW, Moon J, Lim JA, Byun JI, Shin YW, Lee KJ,
              R, Cowell JK, Dalmau J. Investigation of LGI1 as the antigen in limbic   Jung KH, Kim YS, Park KI, Chu K, Lee SK. Clinical manifestations
              encephalitis previously attributed to potassium channels: a case series.   and outcomes of the treatment of patients with GABAB encephalitis. J
              Lancet Neurol 2010;9:776‑85.                        Neuroimmunol 2014;270:45‑50.
           4.   Lancaster E, Lai M, Peng X, Hughes E, Constantinescu R, Raizer   22.  Boronat A, Sabater L, Saiz A, Dalmau J, Graus F. GABA(B) receptor
              J, Friedman D, Skeen MB, Grisold W, Kimura A, Ohta K, Iizuka T,   antibodies in limbic encephalitis and anti‑GAD‑associated neurologic
              Guzman M, Graus F, Moss SJ, Balice‑Gordon R, Dalmau J. Antibodies   disorders. Neurology 2011;76:795‑800.
              to the GABA(B) receptor in limbic encephalitis with seizures: case series   23.  Jarius S, Steinmeyer F, Knobel A, Streitberger K, Hotter B, Horn S,
              and characterisation of the antigen. Lancet Neurol 2010;9:67‑76.  Heuer H, Schreiber SJ, Wilhelm T, Trefzer U, Wildemann B, Ruprecht
           5.   Flanagan EP, McKeon A, Lennon VA, Boeve BF, Trenerry MR, Tan KM,   K. GABAB receptor antibodies in paraneoplastic cerebellar ataxia. J
              Drubach DA,  Josephs KA, Britton JW, Mandrekar JN, Lowe V, Parisi   Neuroimmunol 2013;256:94‑6.
              JE, Pittock SJ. Autoimmune dementia: clinical course and predictors of   24.  DeFelipe‑Mimbrera A,  Masjuan J,  Corral  I,  Villar LM,  Graus  F,
              immunotherapy response. Mayo Clin Proc 2010;85:881‑97.  Garcia‑Barragan N. Opsoclonus‑myoclonus syndrome and limbic
           6.   Quek AM, Britton JW, McKeon A, So E, Lennon VA, Shin C, Klein C,   encephalitis associated with GABAB receptor antibodies in CSF.  J
              Watson RE Jr, Kotsenas AL, Lagerlund TD, Cascino GD, Worrell GA,   Neuroimmunol 2014;272:91‑3.
              Wirrell EC, Nickels KC, Aksamit AJ, Noe KH, Pittock SJ. Autoimmune    25.  Farrant M, Nusser Z. Variations on an inhibitory theme: phasic and tonic
              epilepsy: clinical characteristics and response to immunotherapy. Arch   activation of GABA(A) receptors. Nat Rev Neurosci 2005;6:215‑29.
              Neurol 2012;69:582‑93.                          26.  Tretter V, Moss SJ. GABA(A) receptor dynamics and constructing
           7.   Gable MS, Sheriff H, Dalmau J, Tilley DH, Glaser CA. The frequency   GABAergic synapses. Front Mol Neurosci 2008;1:7.
              of  autoimmune  N‑methyl‑D‑aspartate receptor encephalitis surpasses   27.  Benarroch EE. GABAA receptor heterogeneity, function, and
              that of individual viral etiologies in young individuals enrolled in the   implications for epilepsy. Neurology 2007;68:612‑4.
              California Encephalitis Project. Clin Infect Dis 2012;54:899‑904.  28.  Macdonald RL, Kang JQ, Gallagher MJ. Mutations in GABAA receptor
           8.   Lancaster  E,  Martinez‑Hernandez  E,  Dalmau  J.  Encephalitis  and   subunits associated with genetic epilepsies. J Physiol 2010;588:1861‑9.
              antibodies to synaptic and neuronal cell surface proteins. Neurology   29.  Tanaka M, Olsen RW, Medina MT, Schwartz E, Alonso ME, Duron
              2011;77:179‑89.                                     RM, Castro‑Ortega R, Martinez‑Juarez IE, Pascual‑Castroviejo I,
           9.   Bettler B, Kaupmann K, Mosbacher J, Gassmann M. Molecular   Machado‑Salas J, Silva R, Bailey JN, Bai D, Ochoa A, Jara‑Prado A,
              structure and physiological functions of GABA(B) receptors. Physiol   Pineda G, Macdonald RL, Delgado‑Escueta AV. Hyperglycosylation
              Rev 2004;84:835‑67.                                 and reduced GABA currents of mutated GABRB3 polypeptide


           Neuroimmunol Neuroinfammation | Volume 3 | March 28, 2016                                        91
   95   96   97   98   99   100   101   102   103   104   105